Idenix Pharmaceuticals (IDIX)

[DewDiligence]

Development Timeline for IDX-899 in HIV

Phase-1 in healthy volunteers (multiple, ascending doses for 7 days): completed.

Phase-1b monotherapy in treatment-naïve patients (7 days): start dosing Oct 2007; report preliminary results Dec 2007; report full results Feb 2008 at CROI conference.

Phase-2 in combination with SoC therapy: begin recruitment in 2008.